GS143,IkappaBUbiquitinationInhibitor
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: GS143,IkappaBUbiquitinationInhibitor
產(chǎn)品型號(hào): M60308-2s
產(chǎn)品展商: 其它品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
GS143,IkappaBUbiquitinationInhibitor
GS143,IkappaBUbiquitinationInhibitor
的詳細(xì)介紹
Product Information
Molecular Weight: |
466.46 |
Formula: |
C28H19FN2O4
|
Purity: |
≥98% |
CAS#: |
916232-21-8 |
Solubility: |
DMSO up to 100 mM |
Chemical Name: |
4-(3-benzyl-4-((5-(2-fluorophenyl)furan-2-yl)methylene)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid |
Storage: |
Powder: 4oC 1 year.
DMSO: 4oC 3 month;
-20oC 1 year. |
Biological Activity:
GS143 is selective β-TrCP1 ligase inhibitor, inhibits IκBα ubiquitination with IC50 ~5.2 μM without affecting proteasome activity. It blocks LPS-induced expression of inflammatory cytokines in human myelomonocytic cells. It suppresses antigen-induced NFκB expression, inflammation and mucus production in airways of OVA-sensitized mice.
How to Use:In vitro: GS143 was used at 10-20 μM final concentration in various assays.
In vivo: OVA-sensitized mice were given intranasally with GS143 (16 or 32 μg) and 2 h later, these mice were challenged with inhaled OVA.
Reference:- 1. Hirose K, et al. GS143, an IkappaB ubiquitination inhibitor, inhibits allergic airway inflammation in mice. Biochem Biophys Res Commun. (2008) 374(3):507-11.
- 2. Nakajima H, et al. A novel small-molecule inhibitor of NF-kappaB signaling. (2008) Biochem Biophys Res Commun. 368(4):1007-13.
? ? ??
? ? ??
Products are for research use only. Not for human use.